Pharmaceuticals

  • AKCEA Therapeutics Canada Inc.

    Platinum Sponsor

    Focus: Neurology – Hereditary Transthyretin Amyloidosis (hATTR)

    Akcea Therapeutics is a drug development and commercialization company focused on advancing RNA-targeted antisense therapeutics for patients living with rare diseases including hereditary transthyretin (hATTR) amyloidosis.

    See Our Booth
  • Eisai Limited

    Gold Sponsor

    Focus: Eisai Limited is focused on epilepsy, dementia related diseases and neurodegenerative diseases. Our Canadian products include FYCOMPA and BANZEL.

    Eisai Limited (pronounced ā-zī) is the Canadian pharmaceutical subsidiary of Tokyo-based Eisai Co. Ltd, manufacturers of FYCOMPA and BANZEL. Eisai is a human health care (hhc) company seeking innovative solutions in disease prevention, treatment and care for the health and well-being of people worldwide.

    See Our Booth
  • Hoffmann-La Roche Limited

    Gold Sponsor

    Focus: Psychiatric disorders, Neurodegenerative disorders, Neurodevelopmental disorders

    Roche is a leader in the research and development of pharmaceutical and diagnostic solutions that look beyond today’s horizons and make a profound difference in people’s lives.

    See Our Booth
  • Novartis

    Gold Sponsor

    Focus: Neurology – Multiple Sclerosis, Migraine Cardiology – Heart Failure Immunology/Dermatology/Rheumatology – Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis Respiratory – COPD, asthma Oncology

    Novartis Pharmaceuticals Canada Inc., a leader in the healthcare field, is committed to the discovery, development and marketing of innovative products to improve the well-being of all Canadians.

    See Our Booth
  • Alnylam Pharmaceuticals Canada ULC

    Silver Sponsor

    Focus: Neurology – Hereditary Transthyretin Amyloidosis (hATTR) and Acute Hepatic Porphyrias (AHP)

    Based on Nobel Prize-winning science, Alnylam is leading the translation of RNA interference (RNAi) into a whole new class of innovative medicines

    See Our Booth
  • CSL Behring

    Silver Sponsor

    Focus: We offer a wide range of recombinant and plasma-derived medicines, treating rare and serious conditions like chronic inflammatory demyelinating polyneuropathy.

    A biotechnology company involved for more than a century with research and development related to severe and rare diseases, giving our support to patients with severe diseases.

    See Our Booth
  • Grifols

    Silver Sponsor

    Focus: Neurology

    Grifols is a global pharmaceutical company that develops and produces plasma-derived therapies and manufactures hospital pharmacy products, intravenous solutions, diagnostic tools and medical devices.

    See Our Booth
  • Mitsubishi Tanabe Pharma Canada Inc.

    Silver Sponsor

    Focus: ALS (Amyotrophic lateral sclerosis)

    Mitsubishi Tanabe Pharma Canada, Inc. (MTP-CA) is focused on providing therapies for some of the most difficult-to-treat diseases. We strive to make a difference for those struggling with devastating illnesses.

    See Our Booth
  • Eli Lilly Canada Inc.

    Bronze Sponsor

    Focus: Neurology – Migraine

    Eli Lilly and Company is a global health care leader that unites caring with discovery to make life better for people around the world.

    See Our Booth
  • PTC Therapeutics, Inc

    Bronze Sponsor

    Focus: Duchenne muscular dystrophy, gene therapy & CNS disorders, hATTR Amyloidosis, familial chylomicronemia syndrome, SMA, and oncology

    PTC is a science-led, global biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits
    to patients with rare disorders.

    See Our Booth
  • Teva Canada Innovation

    Bronze Sponsor

    Focus: Neurology – Multiple Sclerosis – Migraine - Pain

    At Teva, we care deeply about the wellbeing of the patients, caregivers and communities who rely on us. We serve 200 million people every day.  From our role as a global leader in generic and brand-name medicines to the innovative solutions we create for our healthcare partners,—here in Canada and around the world.

    See Our Booth
  • abbvie

    Exhibitor

    Focus: The current innovative research of abbvie focuses on compounds that have the potential to treat a variety of chronic disabling neurological conditions.

    Abbvie combines advanced science, expertise and passion to solve serious health issues and have a remarkable impact on people’s lives.

    See Our Booth
  • Paladin Labs

    Exhibitor

    Focus: Neurology – Parkinson’s Disease

    Paladin Labs is a specialty pharmaceutical company, and member of Rx&D, focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian market & select international markets.

    See Our Booth
  • Sunovion Pharmaceuticals Canada Inc.

    Exhibitor

    Focus: Neurology – Partial onset seizures - Epilepsy. Child Neurology – Partial onset seizures - Epilepsy

    Sunovion Pharmaceuticals Canada Inc. (SPCI) is an innovative and entrepreneurial health care company that commercializes Sunovion’s prescription products in Canada. We are focused in the areas of psychiatry, neurology and infectious disease. SPCI is committed to improving patient’s lives in Canada through our people and our products.

    See Our Booth
  • Valeo Pharma Inc.

    Exhibitor

    Focus: Neurology – Parkinsons disease, Multiple Sclerosis. Rheumatology – Gout. Oncology and Oncology supportive care. Woman’s Health

    Valeo Pharma is a fully integrated Canadian specialty pharmaceutical company devoted to providing healthcare professionals and patients with the highest quality specialty products. Valeo Pharma has just launched Onstryv® (safinamide) a new treatment for Parkinsons disease

    See Our Booth
  • Celgene Inc.

    Silver Sponsor

    Focus: Multiple Myeloma (MM), Myelodysplastic Syndromes (MDS), Acute Myelogenous Leukemia (AML), Beta-Thalassemia, Atopic Dermatitis, Psoriatic Arthritis, Psoriasis, Ulcerative Colitis, Crohn’s Disease and Multiple Sclerosis.

    At Celgene Inc., we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

     

    See Our Booth
  • Alexion Pharma Canada

    Supporter

    Focus: Neurology – gMG

    Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through innovation, development and commercialization of life-changing therapies.

    See Our Booth